Cargando…

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective

Detalles Bibliográficos
Autores principales:	Manolis, Efthymios, García‐Arieta, Alfredo, Lindahl, Anders, Kotzagiorgis, Evangelos, Limberg, Jobst, Holte, Øyvind, Paixao, Paulo, Versantvoort, Carolien, Tshinanu, Flora Musuamba, Blake, Kevin, Van Den Heuvel, Michiel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196408/ https://www.ncbi.nlm.nih.gov/pubmed/36628987 http://dx.doi.org/10.1002/psp4.12906

Ejemplares similares

Scientific and regulatory evaluation of empirical pharmacometric models: An application of the risk informed credibility assessment framework
por: Skottheim Rusten, Ine, et al.
Publicado: (2021)

Dose Rationale for Amoxicillin in Neonatal Sepsis When Referral Is Not Possible
por: D’Agate, Salvatore, et al.
Publicado: (2020)

In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products
por: Viceconti, Marco, et al.
Publicado: (2021)

Towards a Generic Tool for Prediction of Meropenem Systemic and Infection-Site Exposure: A Physiologically Based Pharmacokinetic Model for Adult Patients with Pneumonia
por: Thémans, Pauline, et al.
Publicado: (2019)

Simplified Dosing Regimens for Gentamicin in Neonatal Sepsis
por: D’Agate, S., et al.
Publicado: (2021)

Overview of the European Medicines Agency's Experience With Biowaivers in Centralized Applications
por: Lenić, Ines, et al.
Publicado: (2019)

Commentary on the MID3 Good Practices Paper
por: Manolis, Efthymios, et al.
Publicado: (2017)

Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility
por: Musuamba, Flora T., et al.
Publicado: (2021)

Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency
por: Dekker, Marieke J. H. J., et al.
Publicado: (2021)

A generic approach to decipher the mechanistic pathway of heterogeneous protein aggregation kinetics
por: Tikader, Baishakhi, et al.
Publicado: (2021)

Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development: Current Needs, Gaps, and Challenges
por: Musuamba, Flora T., et al.
Publicado: (2020)

Mechanistic modeling of generic orally inhaled drug products: A workshop summary report
por: Walenga, Ross L., et al.
Publicado: (2022)

Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series
por: McAllister, Mark, et al.
Publicado: (2022)

Main Reasons for Registration Application Refusal of Generic and Similar Pharmaceutical Drug Products by the Brazilian Health Regulatory Agency (ANVISA)
por: do Carmo, Ana Cerúlia Moraes, et al.
Publicado: (2017)

Mechanistic modeling of ophthalmic, nasal, injectable, and implant generic drug products: A workshop summary report
por: Tan, Ming‐Liang, et al.
Publicado: (2023)

Global justice and genomics: Toward global agro-genomics agency
por: Korthals, Michiel
Publicado: (2010)

A Theory of Social Agency for Human-Robot Interaction
por: Jackson, Ryan Blake, et al.
Publicado: (2021)

Interchangeability of Generics—Experiences and Outlook Toward Pharmacokinetics Variability and Generic‐Generic Substitution
por: Yu, Yang, et al.
Publicado: (2018)

Gradient and GENERIC Systems in the Space of Fluxes, Applied to Reacting Particle Systems
por: Renger, D. R. Michiel
Publicado: (2018)

The self in conflict: actors and agency in the mediated sequential Simon task
por: Spapé, Michiel M., et al.
Publicado: (2015)

Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs
por: Hammami, Muhammad M., et al.
Publicado: (2017)

Evaluation of a Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union
por: Paixão, Paulo, et al.
Publicado: (2022)

Generic Medicine and Generic Prescribing in Nepal: An Implication for Policymakers
por: Shrestha, Rajeev, et al.
Publicado: (2022)

Generic quality of life in persons with hearing loss: a systematic literature review
por: Nordvik, Øyvind, et al.
Publicado: (2018)

A leap towards enforcing medicines prescribing by generic names in low- and middle-income countries (LMICs): pitfalls, limitations, and recommendations for local drug regulatory agencies
por: Merchant, Hamid A., et al.
Publicado: (2022)

News: Agencies
Publicado: (2011)

News: Agencies
Publicado: (2011)

NEWS – AGENCIES
Publicado: (2017)

NEWS – AGENCIES
Publicado: (2018)

Measures of agency
por: Grünbaum, Thor, et al.
Publicado: (2020)

Purchasing Agency
por: Word, R. C.
Publicado: (1877)

Destructive Agencies
Publicado: (1857)

Destructive Agencies
Publicado: (1876)

Antiretroviral generics
por: Andrieu, Véronique
Publicado: (2012)

Generic Substitution
por: Walley, T.
Publicado: (1993)

Generic Substitution
por: Cheng, Tsung O
Publicado: (1993)

Generics and Alternatives
por: Kochari, Arnold, et al.
Publicado: (2020)

On the mechanistic nature of epistasis in a canonical cis-regulatory element
por: Lagator, Mato, et al.
Publicado: (2017)

Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland
por: O’Leary, A., et al.
Publicado: (2015)

Patient experiences with general practitioners: psychometric performance of the generic PEQ-GP instrument among patients with chronic conditions
por: Bjertnæs, Øyvind A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pfudqhp8ta4vaqjbvd1dboetil